JB Capital LLC Sells 65 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

JB Capital LLC reduced its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.1% in the third quarter, HoldingsChannel reports. The firm owned 433 shares of the medical equipment provider’s stock after selling 65 shares during the period. JB Capital LLC’s holdings in Intuitive Surgical were worth $213,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the business. Vanguard Group Inc. increased its holdings in Intuitive Surgical by 1.6% in the first quarter. Vanguard Group Inc. now owns 30,868,620 shares of the medical equipment provider’s stock worth $12,319,358,000 after purchasing an additional 493,126 shares in the last quarter. Capital World Investors grew its stake in Intuitive Surgical by 1.0% in the first quarter. Capital World Investors now owns 7,284,269 shares of the medical equipment provider’s stock valued at $2,907,079,000 after acquiring an additional 73,634 shares during the period. American Century Companies Inc. grew its stake in Intuitive Surgical by 3.0% in the second quarter. American Century Companies Inc. now owns 2,398,193 shares of the medical equipment provider’s stock valued at $1,066,837,000 after acquiring an additional 70,556 shares during the period. Clearbridge Investments LLC grew its stake in Intuitive Surgical by 1.6% in the second quarter. Clearbridge Investments LLC now owns 1,981,297 shares of the medical equipment provider’s stock valued at $881,380,000 after acquiring an additional 30,449 shares during the period. Finally, Assenagon Asset Management S.A. grew its stake in Intuitive Surgical by 15.4% in the second quarter. Assenagon Asset Management S.A. now owns 1,483,406 shares of the medical equipment provider’s stock valued at $659,893,000 after acquiring an additional 197,841 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the company’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the transaction, the senior vice president now directly owns 3,001 shares in the company, valued at $1,461,006.84. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the company’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the transaction, the senior vice president now directly owns 3,001 shares in the company, valued at $1,461,006.84. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Robert Desantis sold 396 shares of the company’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $486.88, for a total value of $192,804.48. Following the completion of the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,680,761.28. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 68,246 shares of company stock worth $33,839,308. 0.90% of the stock is owned by company insiders.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $524.28 on Friday. Intuitive Surgical, Inc. has a 52-week low of $269.49 and a 52-week high of $525.00. The firm has a market cap of $186.74 billion, a price-to-earnings ratio of 84.29, a PEG ratio of 4.99 and a beta of 1.39. The business’s fifty day moving average is $492.30 and its 200 day moving average is $450.05.

Analysts Set New Price Targets

ISRG has been the subject of a number of research reports. Piper Sandler reissued an “overweight” rating and issued a $538.00 price objective (up previously from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a research report on Friday, October 18th. Evercore ISI reaffirmed a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Mizuho lifted their target price on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus target price of $513.74.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.